These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22126908)

  • 1. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
    Mazali FC; Johnson RJ; Mazzali M
    Nephron Exp Nephrol; 2012; 120(1):e12-9. PubMed ID: 22126908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricemia exacerbates chronic cyclosporine nephropathy.
    Mazzali M; Kim YG; Suga S; Gordon KL; Kang DH; Jefferson JA; Hughes J; Kivlighn SD; Lan HY; Johnson RJ
    Transplantation; 2001 Apr; 71(7):900-5. PubMed ID: 11349724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
    Pichler RH; Franceschini N; Young BA; Hugo C; Andoh TF; Burdmann EA; Shankland SJ; Alpers CE; Bennett WM; Couser WG
    J Am Soc Nephrol; 1995 Oct; 6(4):1186-96. PubMed ID: 8589285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.
    Kosugi T; Nakayama T; Heinig M; Zhang L; Yuzawa Y; Sanchez-Lozada LG; Roncal C; Johnson RJ; Nakagawa T
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F481-8. PubMed ID: 19458127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.
    Young BA; Burdmann EA; Johnson RJ; Alpers CE; Giachelli CM; Eng E; Andoh T; Bennett WM; Couser WG
    Kidney Int; 1995 Aug; 48(2):439-48. PubMed ID: 7564111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia.
    Chen G; Jia P
    Pharmacol Rep; 2016 Aug; 68(4):782-6. PubMed ID: 27258609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    Chen CC; Hsu YJ; Lee TM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of jianpihuashi decoction on rats with hyperuricemia].
    Chen JW; Zhou Y; Xue ZY; Li C; Guo J; Zhou LY; Jiang JM
    Zhong Yao Cai; 2013 Sep; 36(9):1486-9. PubMed ID: 24620698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental heat stress nephropathy and liver injury are improved by allopurinol.
    Roncal-Jimenez CA; Sato Y; Milagres T; Andres Hernando A; García G; Bjornstad P; Dawson JB; Sorensen C; Newman L; Krisher L; Madero M; Glaser J; Gárcía-Trabanino R; Romero EJ; Song Z; Jensen T; Kuwabara M; Rodriguez-Iturbe B; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F726-F733. PubMed ID: 29667911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Wang D; Sun L; Zhang G; Liu Y; Liang Z; Zhao J; Yin S; Su M; Zhang S; Wei Y; Liu H; Liang D; Li Y
    Cardiovasc Toxicol; 2021 Mar; 21(3):192-205. PubMed ID: 33099748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1994; 9(5):548-51. PubMed ID: 8090336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats].
    Chen GL; Zhu LR; Na S; Li L
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2348-53. PubMed ID: 24199570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hyperuricemia a risk factor for arteriosclerosis? Uric acid and arteriosclerosis in apolipoprotein e-deficient mice.
    Wakuda H; Uchida S; Ikeda M; Tabuchi M; Akahoshi Y; Shinozuka K; Yamada S
    Biol Pharm Bull; 2014; 37(12):1866-71. PubMed ID: 25451835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
    Li C; Sun BK; Lim SW; Song JC; Kang SW; Kim YS; Kang DH; Cha JH; Kim J; Yang CW
    Transplantation; 2005 Jun; 79(11):1522-9. PubMed ID: 15940041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.
    Nakata T; Ikeda S; Koga S; Yonekura T; Tsuneto A; Doi Y; Fukae S; Minami T; Kawano H; Maemura K
    Int Heart J; 2020 Sep; 61(5):984-992. PubMed ID: 32921665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy.
    Castoldi G; Carletti R; Ippolito S; Colzani M; Barzaghi F; Stella A; Zerbini G; Perseghin G; Zatti G; di Gioia CRT
    Acta Diabetol; 2021 Aug; 58(8):1059-1070. PubMed ID: 33760995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine in osteopontin null mice.
    Mazzali M; Hughes J; Dantas M; Liaw L; Steitz S; Alpers CE; Pichler RH; Lan HY; Giachelli CM; Shankland SJ; Couser WG; Johnson RJ
    Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.